Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001341004-08-001738
Filing Date
2008-08-01
Accepted
2008-08-01 13:12:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 EARNINGS CONFERENCE CALL TRANSCRIPT fresenius425.htm 425 263366
2 fresenius4252.jpg GRAPHIC 12469
3 fresenius4254.jpg GRAPHIC 6373
  Complete submission text file 0001341004-08-001738.txt   291959
Mailing Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837
Business Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837 847-969-2700
APP Pharmaceuticals, Inc. (Subject) CIK: 0001141399 (see all company filings)

EIN.: 680389419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-33407 | Film No.: 08984345
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808
Business Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 49 6172 608 2327
Fresenius Kabi Pharmaceuticals Holding, LLC (Filed by) CIK: 0001439449 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations